Key result
Non-Black patients with end-stage renal disease had an 8.6-fold greater odds of having an abdominal vascular calcification score of ≥ 1 at 5-year follow-up compared to Black patients, after adjusting for parathyroidectomy.
Why the study?
There was no published data on the association of ethnic differences in vascular calcification and survival in ESRD from Sub-Saharan Africa.
Cohort (n=66)
Single-blind
No
Odds Ratio: 8.6
p-value: p=0.031
In South African patients with ESRD, non-Blacks showed greater progression of vascular calcification compared to Blacks after adjusting for parathyroidectomy rates, though this did not translate to a survival difference in this small cohort.
Racial disparity in vascular calcification progression should not yet change practice; hypothesis-generating for mechanisms and outcomes in ESRD.
BACKGROUND Vascular calcification is a risk factor for cardiovascular morbidity and mortality in patients with end stage renal disease (ESRD). In Western countries, Blacks with ESRD appear to have lesser degrees of vascular calcification compared to non-Blacks. However, there is no published data on the association of ethnic differences in vascular calcification and survival in ESRD from Sub-Saharan Africa. METHODS This study assessed 5-year changes in vascular calcification and mortality in a previously published cohort of patients with ESRD. Vascular calcification was assessed by abdominal aortic calcification score and vascular stiffness by pulse wave velocity. RESULTS Sixty-six of the original 74 participants, studied at baseline, were identified. The median age was 46.6 years (37.6-59.2) and 57.6% were women. Abdominal aortic calcification showed no progression among Blacks [baseline range 0-5, follow up range 0-8 (p=1.00)], but a non-significant trend to progression among non-Blacks [baseline range 0-19, follow up range 0-22 (p=0.066)]. Black participants did not display a survival advantage (p=0.870). Overall, sepsis was the most common cause of mortality (64% of those with an identifiable cause of death). Non-Blacks had higher parathyroidectomy rates than Blacks with 9/30 cases compared to 2/36 (p=0.036). After adjustment for parathyroidectomy at follow up, the odds ratio of having abdominal vascular calcification score of ≥1 amongst non-Blacks was 8.6-fold greater compared to Blacks (p= 0.03). Central aortic systolic pressures (CASP) and pulse wave velocities (PWV) were higher in the study population than age matched normative values. At follow up, a positive correlation (r=0.5) was observed between PWV and abdominal aortic calcification (p=0.047). Elevated baseline coronary artery calcification score and FGF-23 level at baseline were not associated with a difference in mortality. CONCLUSION There was no significant progression in vascular calcification among Blacks. After adjusting for increased parathyroidectomy rates, there was a greater progression of vascular calcification amongst non-Blacks compared to Blacks highlighting possible ethnic differences in calcium phosphate metabolism in patients with ESRD. Lack of vascular calcification progression in Blacks was not associated with improved survival, but the sample size was small.
No takes yet. Share an insight, caveat, or question.
Simba et al. (2019) conducted a cohort in End-stage renal disease (n=66). Non-Black ethnicity vs. Black ethnicity was evaluated on Abdominal vascular calcification score of ≥ 1 at 5-year follow-up (OR 8.6, p=0.031). Non-Black patients with end-stage renal disease had an 8.6-fold greater odds of having an abdominal vascular calcification score of ≥ 1 at 5-year follow-up compared to Black patients, after adjusting for parathyroidectomy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: